GSK Loses Bid To Bar Testimony On Avandia Risks
By Erin Marie Daly ( January 5, 2011, 1:54 PM EST) -- GlaxoSmithKline PLC has lost its bid to block three doctors from testifying about the alleged health risks of Avandia in a multidistrict litigation alleging the company concealed the diabetes medication's potential to cause heart attack and stroke in some patients....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.